Conformis, Inc. CFMS
Set alert
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 17.45M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.48
- Beta
- 1.43
- Short ratio
- 6.43
- Inst. own
- 39.77%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 2, 2023
- 50-d avg
- 1.46
- 200-d avg
- 2.31
- 1y target
- 50.00
News
2 years ago businesswire.com
Scaling a Personalized Portfolio: restor3d Completes Key Initiative Following Conformis Acquisition
DURHAM, N.C.--(BUSINESS WIRE)-- #3DPrinting--On September 5, 2023, restor3d, Inc. finalized its previously announced acquisition of Conformis, Inc. With this merger complete, there is tremendous…
3 years ago globenewswire.com
restor3d Completes Acquisition of Conformis
Combination Creates the World's Preeminent Producer of Personalized Orthopedic Medical Devices, with Unmatched Additive Manufacturing Capabilities Combination Creates the World's Preeminent Producer…
3 years ago globenewswire.com
Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger with restor3d
BILLERICA, Mass., Aug. 21, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS ), a leading medical technology company featuring personalized knee and hip replacement products, announced today…
3 years ago zacks.com
ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue Estimates
ConforMIS (CFMS) came out with a quarterly loss of $1.78 per share versus the Zacks Consensus Estimate of a loss of $1.32. This compares to loss of $2.25 per share a year ago.
3 years ago globenewswire.com
Conformis Reports Second Quarter 2023 Financial Results
BILLERICA, Mass., Aug. 02, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today…
3 years ago businesswire.com
CONFORMIS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Conformis, Inc. - CFMS
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Conformis, Inc.…
3 years ago prnewswire.com
Shareholder Alert: Ademi LLP investigates whether Conformis, Inc. has obtained a Fair Price in its transaction with restor3d
MILWAUKEE , June 23, 2023 /PRNewswire/ -- Ademi LLP is investigating Conformis (NASDAQ: CFMS) for possible breaches of fiduciary duty and other violations of law in its transaction with restor3d.…
3 years ago headlinesoftoday.com
Shareholder Alert: Ademi LLP investigates whether Conformis, Inc. has obtained a Fair Price in its transaction with restor3d
MILWAUKEE, June 23, 2023 /PRNewswire/ — Ademi LLP is investigating Conformis (NASDAQ: CFMS) for possible breaches of fiduciary duty and other violations of law in its transaction with restor3d. Click…
3 years ago businesswire.com
CFMS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Conformis, Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Conformis, Inc. (NASDAQ: CFMS) to restor3d for $2.27 per share in cash is fair to…
3 years ago marketwatch.com
Conformis stock nearly doubles in active trading after cash buyout deal with Restor3d
Shares of Conformis Inc. CFMS, -2.11% rocketed 90.5% to pace all premarket gainers in active trading Friday, after the orthopedic patient care company announced an agreement to be acquired by…
3 years ago globenewswire.com
Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in Cash
Combination creates a leading personalized 3D-printed orthopedic medical device company Combination creates a leading personalized 3D-printed orthopedic medical device company
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 199 companies reached new 52-week lows.
-
3 years ago benzinga.com
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2023
Benzinga's Top Ratings Upgrades, Downgrades For May 9, 2023
3 years ago zacks.com
ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue Estimates
ConforMIS (CFMS) came out with a quarterly loss of $1.32 per share versus the Zacks Consensus Estimate of a loss of $1.56. This compares to loss of $2.25 per share a year ago.
3 years ago seekingalpha.com
Conformis, Inc. (CFMS) Q1 2023 Earnings Call Transcript
Conformis, Inc. (NASDAQ:CFMS ) Q1 2023 Earnings Conference Call May 8, 2023 8:30 AM ET Company Participants Mark Augusti - President and CEO Bob Howe - CFO and Treasurer Conference Call Participants…
-
3 years ago benzinga.com
Earnings Scheduled For May 8, 2023
Companies Reporting Before The Bell • HNI (NYSE:HNI) is likely to report quarterly loss at $0.03 per share on revenue of $462.26 million.
3 years ago globenewswire.com
Conformis Reports First Quarter 2023 Financial Results
BILLERICA, Mass., May 08, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today…
3 years ago globenewswire.com
Conformis, Inc. to Announce Financial Results for Its First Quarter on May 8, 2023
BILLERICA, Mass., April 13, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it…
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday, 95 stocks hit new 52-week lows.
3 years ago globenewswire.com
Conformis Launches Patient Awareness Campaign to Highlight the Benefits of Personalized Knee Replacement Procedures
The campaign underscores that patients have a choice of implant when undergoing total knee arthroscopy, and that they should advocate for the many benefits of a fully personalized knee The campaign…
3 years ago zacks.com
ConforMIS (CFMS) Moves to Buy: Rationale Behind the Upgrade
ConforMIS (CFMS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
3 years ago seekingalpha.com
Conformis, Inc. (CFMS) Q4 2022 Earnings Call Transcript
Conformis, Inc. (NASDAQ:CFMS ) Q4 2022 Results Conference Call March 1, 2023 4:30 PM ET Company Participants Mark Augusti - President and Chief Executive Officer Bob Howe - CFO and Treasurer…
3 years ago globenewswire.com
Conformis, Inc. Reports Fourth Quarter and Year End 2022 Financial Results
BILLERICA, Mass., March 01, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) an orthopedic medical device company that features personalized knee and hip replacement products, announced today…
-
3 years ago benzinga.com
Earnings Scheduled For March 1, 2023
Companies Reporting Before The Bell • Globalstar (AMEX:GSAT) is expected to report quarterly loss at $0.01 per share on revenue of $38.75 million.
3 years ago globenewswire.com
Conformis, Inc. to Participate in Upcoming Investor Conferences
BILLERICA, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today…
-
3 years ago benzinga.com
Why TuanChe Shares Are Trading Lower By 76%? Here Are 48 Stocks Moving In Monday's Mid-Day Session
Gainers Imago BioSciences, Inc. (NASDAQ: IMGO) shares jumped 104% to $35.50 after Merck announced it would acquire the company for $36 per share in cash.
-
3 years ago benzinga.com
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday
Gainers
-
3 years ago benzinga.com
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
Gainers
-
3 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 283 companies set new 52-week lows.
-
3 years ago benzinga.com
Earnings Scheduled For November 2, 2022
Companies Reporting Before The Bell • Nomura Holdings (NYSE:NMR) is likely to report earnings for its second quarter.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's trading, 517 companies set new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 838 companies hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Thursday
On Thursday, 930 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Friday
On Friday, 122 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 250 stocks hit new 52-week lows.
-
4 years ago benzinga.com
Earnings Scheduled For August 8, 2022
Companies Reporting Before The Bell • Pyxis Tankers (NASDAQ:PXS) is likely to report earnings for its second quarter.
-
4 years ago benzinga.com
62 Biggest Movers From Yesterday
Gainers Missfresh Limited (NASDAQ: MF) jumped 51.1% to close at $0.2450 on Wednesday.
-
4 years ago benzinga.com
99 Biggest Movers From Yesterday
Gainers Armstrong Flooring, Inc. (NYSE: AFI) shares jumped 237% to settle at $0.49 on Wednesday after a 13D filing showed Esopus Creek Advisors LLC disclosed a 5.1% active stake in the company.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday, 807 companies reached new 52-week lows.
-
4 years ago benzinga.com
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
-
4 years ago benzinga.com
Stocks That Hit 52-Week Lows On Wednesday
Wednesday's session saw 784 companies set new 52-week lows.
-
4 years ago benzinga.com
Earnings Scheduled For November 3, 2021
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Wednesday
Before 10 a.m. ET Wednesday, 138 stocks hit new 52-week highs.
-
5 years ago benzinga.com
Earnings Scheduled For August 4, 2021
Companies Reporting Before The Bell • UroGen Pharma (NASDAQ:URGN) is projected to report earnings for its second quarter.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Monday
Before 10 a.m. ET on Monday, 201 companies set new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Tuesday
This morning 85 companies set new 52-week highs.
-
5 years ago benzinga.com
Stocks That Hit 52-Week Highs On Friday
On Friday morning, 126 companies achieved new highs for the year.
-
5 years ago benzinga.com
Earnings Scheduled For May 5, 2021
Companies Reporting Before The Bell • Monmouth Real Estate (NYSE:MNR) is likely to report earnings for its second quarter.
-
5 years ago benzinga.com
82 Biggest Movers From Yesterday
Gainers Five Prime Therapeutics, Inc. (NASDAQ: FPRX) shares surged 78.7% to close at $38.00 on Thursday after Amgen announced plans to acquire the company for $1.9 billion.
-
5 years ago benzinga.com
Earnings Scheduled For March 3, 2021
Companies Reporting Before The Bell • Brown Forman Inc Class A Common Stock (NYSE:BF) is likely to report earnings for its third quarter.